| 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and meta-analysis FE von Eyben, M Picchio, R von Eyben, H Rhee, G Bauman European urology focus 4 (5), 686-693, 2018 | 273 | 2018 |
| Adverse effects of androgen‐deprivation therapy in prostate cancer and their management H Rhee, JH Gunter, P Heathcote, K Ho, P Stricker, NM Corcoran, ... BJU international 115, 3-13, 2015 | 147 | 2015 |
| Prostate specific membrane antigen positron emission tomography may improve the diagnostic accuracy of multiparametric magnetic resonance imaging in localized prostate cancer H Rhee, P Thomas, B Shepherd, S Gustafson, I Vela, PJ Russell, ... The Journal of urology 196 (4), 1261-1267, 2016 | 132 | 2016 |
| Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour H Rhee, J Blazak, CM Tham, KL Ng, B Shepherd, M Lawson, J Preston, ... EJNMMI research 6, 1-6, 2016 | 125 | 2016 |
| A review of prostate-specific membrane antigen (PSMA) positron emission tomography (PET) in renal cell carcinoma (RCC) T Ahn, MJ Roberts, A Abduljabar, A Joshi, M Perera, H Rhee, S Wood, ... Molecular imaging and biology 21, 799-807, 2019 | 62 | 2019 |
| Metabolic syndrome and prostate cancer: a review of complex interplay amongst various endocrine factors in the pathophysiology and progression of prostate cancer H Rhee, I Vela, E Chung Hormones and Cancer 7, 75-83, 2016 | 37 | 2016 |
| Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease H Rhee, KL Ng, BWC Tse, MC Yeh, PJ Russell, C Nelson, P Thomas, ... Pathology 48 (6), 613-616, 2016 | 32 | 2016 |
| Prostate specific membrane antigen (PSMA) expression in vena cava tumour thrombi of clear cell renal cell carcinoma suggests a role for PSMA-driven tumour neoangiogenesis G Morgantetti, KL Ng, H Samaratunga, H Rhee, GC Gobe, ST Wood Translational andrology and urology 8 (Suppl 2), S147, 2019 | 25 | 2019 |
| The role of dual tracer PSMA and FDG PET/CT in renal cell carcinoma (RCC) compared to conventional imaging: A multi-institutional case series with intra-individual comparison A Tariq, M Kwok, A Pearce, H Rhee, S Kyle, P Marsh, S Raveenthiran, ... Urologic Oncology: Seminars and Original Investigations 40 (2), 66. e1-66. e9, 2022 | 24 | 2022 |
| The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a … A Joshi, MJ Roberts, M Perera, E Williams, H Rhee, D Pryor, M Lehman, ... Clinical & Experimental Metastasis 37, 551-560, 2020 | 24 | 2020 |
| The use of MRI and PET imaging studies for prostate cancer management: brief update, clinical recommendations, and technological limitations M Mansbridge, E Chung, H Rhee Medical Sciences 7 (8), 85, 2019 | 16 | 2019 |
| Incidental malignancies identified during staging for prostate cancer with 68Ga prostate-specific membrane antigen HBED-CC positron emission tomography imaging A Joshi, C Nicholson, H Rhee, S Gustafson, K Miles, I Vela Urology 104, e3-e4, 2017 | 12 | 2017 |
| PSMA PET may improve the diagnostic accuracy of mpMRI in localised prostate cancer as confirmed by whole-mount histopathology H Rhee, P Thomas, B Shepherd, S Greenslade, I Vela, PJ Russell, ... J Urol 196, 1261-1267, 2016 | 10 | 2016 |
| Characterization of tumor thrombus in renal cell carcinoma with prostate specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) A Tariq, S McGeorge, A Pearce, H Rhee, S Wood, S Kyle, P Marsh, ... Urologic Oncology: Seminars and Original Investigations 40 (6), 276. e1-276. e9, 2022 | 8 | 2022 |
| PSMA-PET/CT-avid metastatic prostate cancer to the penis MM Mansbridge, A Strahan, J Parker, H Rhee BMJ Case Reports CP 13 (3), e233522, 2020 | 8 | 2020 |
| Weaponizing natural killer cells for solid cancer immunotherapy JKM Wong, R Dolcetti, H Rhee, F Simpson, F Souza-Fonseca-Guimaraes Trends in Cancer 9 (2), 111-121, 2023 | 7 | 2023 |
| A novel liver-targeted testosterone therapy for sarcopenia in androgen deprived men with prostate cancer H Rhee, A Navaratnam, I Oleinikova, D Gilroy, Y Scuderi, P Heathcote, ... Journal of the Endocrine Society 5 (9), bvab116, 2021 | 7 | 2021 |
| Impact of physical exercise program interventions on erectile function and cardiovascular health in males with prostate cancer E Chung, H Rhee The World Journal of Men's Health 40 (3), 361, 2022 | 6 | 2022 |
| Imaging tumour thrombus of clear cell renal cell carcinoma: FDG PET or PSMA PET? Direct in vivo comparison of two technologies S Saadat, B Tie, S Wood, I Vela, H Rhee Urology Case Reports 16, 4-5, 2018 | 6 | 2018 |
| Lower urinary tract imaging in pelvic fracture: an 11‐year review of genitourinary complications and clinical outcomes W Choi, H Rhee, E Chung ANZ Journal of Surgery 87 (4), 257-261, 2017 | 5 | 2017 |
